Watch These Hot Ones: Oshkosh Corporation (NYSE:OSK), Westell Technologies (NASDAQ:WSTL), Village Super Market (NASDAQ:VLGEA), AbbVie (NYSE:ABBV), HTG Molecular Diagnostics (NASDAQ:HTGM)

Oshkosh Corporation (NYSE:OSK) shares moved down -0.76% in last trading session and ended the day at $39.27. OSK Gross Margin is 17.40% and its has a return on assets of 6.40%. Oshkosh Corporation (NYSE:OSK) quarterly performance is -23.91%.

Oshkosh Corporation is a leading designer, manufacturer and marketer of a broad range of specialty access equipment, commercial, fire & emergency and military vehicles and vehicle bodies. Oshkosh Corporation manufactures, distributes and services products under the brands of Oshkosh®, JLG®, Pierce®,McNeilus®, Jerr-Dan®, Frontline™, CON-E-CO®, London® and IMT®.

Westell Technologies, Inc., headquartered in Aurora, Illinois, is a leading provider of in-building wireless, intelligent site management, cell site optimization, and outside plant solutions focused on innovation and differentiation at the edge of telecommunication networks, where end users connect. The Company’s comprehensive set of products and solutions enable telecommunication service providers and other network operators to improve network performance and reduce operating expenses.

Westell Technologies, Inc. (NASDAQ:WSTL) ended the last trading day at $1.15. Company weekly volatility is calculated as 6.15% and price to cash ratio as 1.90. Westell Technologies, Inc. (NASDAQ:WSTL) showed a weekly performance of -2.54%.

Westell Technologies, Inc. (NASDAQ:WSTL), a leading provider of in-building wireless, intelligent site management, cell site optimization, and outside plant solutions, announced it presented at the Drexel Hamilton Conference in New York City on September 10 at 9:40 a.m. EDT.

On 11 September, Village Super Market Inc. (NASDAQ:VLGEA) shares moved down -0.30% and was closed at $26.74. VLGEA EPS growth in last 5 year was -29.40%. Village Super Market Inc. (NASDAQ:VLGEA) year to date (YTD) performance is -0.74%.

Village Super Market, Inc. (Village) is a United States of America-based company which operates a chain of 29 ShopRite supermarkets, eighteen of which are located in northern New Jersey, eight in southern New Jersey, two in Maryland and one in northeastern Pennsylvania. The Company is a member of Wakefern Food Corporation (Wakefern), the nation’s largest retailer-owned food cooperative and owner of the ShopRite name.

The Board of Directors of Village Super Market, Inc. (NASDAQ:VLGEA) declared quarterly cash dividends of $0.25 per Class A common share and $0.1625 per Class B common share. The dividends will be payable on October 22, 2015 to shareholders of record at the close of business on October 1, 2015.

AbbVie Inc. (NYSE:ABBV) shares moved down -0.39% in last trading session and ended the day at $59.35. ABBV Gross Margin is 80.70% and its has a return on assets of 6.10%. AbbVie Inc. (NYSE:ABBV) quarterly performance is -10.83%.

AbbVie Inc. (AbbVie) is a global, research-based biopharmaceutical company. The Company develops and markets therapies that address a range of diseases. The Company’s products are focused on treating conditions, such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis and Crohn’s disease; hepatitis C (HCV); human immunodeficiency virus (HIV); endometriosis; thyroid disease; Parkinson’s disease; complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone.

AbbVie (NYSE:ABBV), a global biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved HUMIRA® (adalimumab) for the treatment of moderate to severe hidradenitis suppurativa (HS). HUMIRA is now the first and only FDA-approved therapy for adults with HS.

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) caters to the Healthcare space. Its weekly performance is 25.61%. On the last day of trading company shares ended up $7.16. HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) distance from 50-day simple moving average (SMA50) is -13.70%.

HTG Molecular Diagnostics Inc is a United States-based company that provides products for miRNA, and mRNA measurement for translational research/medicine and molecular diagnostics. Its qNPA molecular technology platform is suited for detecting changes in gene expression levels; especially from formalin-fixed, paraffin-embedded (FFPE) tissue and other biological sample types. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct.

Equities research analysts at Canaccord Genuity cut their price objective on shares of HTG Molecular Diagnostics (NASDAQ:HTGM) from $17.00 to $12.00 in a research note issued on Monday, Analyst Ratings Network.com reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity’s price objective indicates a potential upside of 117.39% from the stock’s current price.